{"id":"p-3074","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-15%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Vomiting"}]},"_chembl":{"chemblId":"CHEMBL1354658","moleculeType":"Small molecule","molecularWeight":"453.36"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"P-3074 works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys, reducing glucose reabsorption and lowering blood glucose levels. This mechanism is particularly effective in patients with type 2 diabetes.","oneSentence":"P-3074 is a small molecule that targets the SGLT2 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:25:12.447Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT03004469","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia","status":"COMPLETED","sponsor":"Polichem S.A.","startDate":"2016-08-02","conditions":"Alopecia, Androgenetic","enrollment":458},{"nctId":"NCT02791243","phase":"PHASE1","title":"Photosensitization Study in Androgenetic Alopecia","status":"COMPLETED","sponsor":"Polichem S.A.","startDate":"2016-05-09","conditions":"Androgenetic Alopecia","enrollment":58}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["finasteride topical solution"],"phase":"phase_3","status":"active","brandName":"P-3074","genericName":"P-3074","companyName":"Polichem S.A.","companyId":"polichem-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"P-3074 is a small molecule that targets the SGLT2 receptor. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}